These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 36220850)

  • 1. The spatial-temporal distribution and etiological characteristics of hand-foot-and-mouth disease before and after EV‑A71 vaccination in Kunming, China, 2017-2020.
    Wang M; Chen T; Peng J; Luo Y; Du L; Lu Z; He J; Liu C; Gan Q; Ma W; Cun Z; Zheng Q; Chen W; Chen Y; Han M; Liu G; Li J
    Sci Rep; 2022 Oct; 12(1):17028. PubMed ID: 36220850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China.
    Jiang H; Zhang Z; Rao Q; Wang X; Wang M; Du T; Tang J; Long S; Zhang J; Luo J; Pan Y; Chen J; Ma J; Liu X; Fan M; Zhang T; Sun Q
    Emerg Microbes Infect; 2021 Dec; 10(1):619-628. PubMed ID: 33682641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.
    Takahashi S; Liao Q; Van Boeckel TP; Xing W; Sun J; Hsiao VY; Metcalf CJ; Chang Z; Liu F; Zhang J; Wu JT; Cowling BJ; Leung GM; Farrar JJ; van Doorn HR; Grenfell BT; Yu H
    PLoS Med; 2016 Feb; 13(2):e1001958. PubMed ID: 26882540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis of 555 outpatients with hand, foot and mouth diseases caused by different enteroviruses].
    Cui P; Li Y; Zhou CC; Zhou YH; Song CL; Qiu Q; Wang F; Guo C; Han SJ; Liang L; Yuan Y; Zeng MY; Yue J; Long L; Qin XH; Li Z; Chen XL; Zou YP; Cheng YB; Yu HJ
    Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):445-451. PubMed ID: 31216802
    [No Abstract]   [Full Text] [Related]  

  • 5. Age-time-specific transmission of hand-foot-and-mouth disease enterovirus serotypes in Vietnam: A catalytic model with maternal immunity.
    Chen Y; Nguyet LA; Nhan LNT; Qui PT; Nhu LNT; Hong NTT; Ny NTH; Anh NT; Thanh LK; Phuong HT; Vy NHT; Thanh NTL; Khanh TH; Hung NT; Viet DC; Nam NT; Chau NVV; van Doorn HR; Tan LV; Clapham H
    Epidemics; 2024 Mar; 46():100754. PubMed ID: 38428358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013-2014.
    Yao X; Bian LL; Lu WW; Li JX; Mao QY; Wang YP; Gao F; Wu X; Ye Q; Li XL; Zhu FC; Liang Z
    Hum Vaccin Immunother; 2017 Apr; 13(4):823-830. PubMed ID: 27768527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-infection and enterovirus B: post EV-A71 mass vaccination scenario in China.
    Guo W; Xu D; Cong S; Du Z; Li L; Zhang M; Feng C; Bao G; Sun H; Yang Z; Ma S
    BMC Infect Dis; 2022 Aug; 22(1):671. PubMed ID: 35927711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology and clinical characteristics of enteroviruses associated HFMD in Chengdu, China, 2013-2022.
    Yang Q; Liu F; Chang L; Lai S; Teng J; Duan J; Jian H; Liu T; Che G
    Virol J; 2023 Sep; 20(1):202. PubMed ID: 37661256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemical and etiological study on hand, foot and mouth disease following EV-A71 vaccination in Xiangyang, China.
    Meng XD; Tong Y; Wei ZN; Wang L; Mai JY; Wu Y; Luo ZY; Li S; Li M; Wang S; Wei S; Gong W; Zhang W; Hu X; Huang J; Shi J; Yang G; Meng S; Wang Z; Guan X; Shen S
    Sci Rep; 2020 Dec; 10(1):20909. PubMed ID: 33262488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coxsackievirus A6 was the most common enterovirus serotype causing hand, foot, and mouth disease in Shiyan City, central China.
    Li JF; Zhang CJ; Li YW; Li C; Zhang SC; Wang SS; Jiang Y; Luo XB; Liao XJ; Wu SX; Lin L
    World J Clin Cases; 2022 Nov; 10(31):11358-11370. PubMed ID: 36387823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.
    Liu CC; Guo MS; Wu SR; Lin HY; Yang YT; Liu WC; Chow YH; Shieh DB; Wang JR; Chong P
    Antiviral Res; 2016 May; 129():58-66. PubMed ID: 26899790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coxsackieviruses A6 and A16 associated with hand, foot, and mouth disease in Vietnam, 2008-2017: Essential information for rational vaccine design.
    Hoa-Tran TN; Dao ATH; Nguyen AT; Kataoka C; Takemura T; Pham CH; Vu HM; Hong TTT; Ha NTV; Duong TN; Thanh NTH; Shimizu H
    Vaccine; 2020 Dec; 38(52):8273-8285. PubMed ID: 33223308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: epidemiology, etiology, and disease burden.
    Ji H; Fan H; Lu PX; Zhang XF; Ai J; Shi C; Huo X; Bao CJ; Shan J; Jin Y
    BMC Infect Dis; 2019 Jan; 19(1):79. PubMed ID: 30669973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial-temporal-demographic and virological changes of hand, foot and mouth disease incidence after vaccination in a vulnerable region of China.
    Huang L; Wang T; Liu X; Fu Y; Zhang S; Chu Q; Nie T; Tu H; Cheng J; Fan Y
    BMC Public Health; 2022 Aug; 22(1):1468. PubMed ID: 35915424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of single-step multiplex real-time RT-PCR assays for rapid diagnosis of enterovirus 71, coxsackievirus A6, and A16 in patients with hand, foot, and mouth disease.
    Puenpa J; Suwannakarn K; Chansaenroj J; Vongpunsawad S; Poovorawan Y
    J Virol Methods; 2017 Oct; 248():92-99. PubMed ID: 28662914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine.
    Yang B; Liu F; Liao Q; Wu P; Chang Z; Huang J; Long L; Luo L; Li Y; Leung GM; Cowling BJ; Yu H
    Euro Surveill; 2017 Dec; 22(50):. PubMed ID: 29258646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology and clinical features of hand, foot and mouth disease requiring hospitalization after the use of enterovirus A71 inactivated vaccine in chengdu, China, 2017-2022: a descriptive study.
    Duan X; Zhang C; Wang X; Ren X; Peng H; Tang X; Zhang L; Chen Z; Ye Y; Zheng M; Zhong W; Chen X; Zeng Y; Yuan P; Long L
    Emerg Microbes Infect; 2022 Dec; 11(1):2510-2519. PubMed ID: 36103331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic Reproduction Number of Enterovirus 71 and Coxsackievirus A16 and A6: Evidence From Outbreaks of Hand, Foot, and Mouth Disease in China Between 2011 and 2018.
    Zhang Z; Liu Y; Liu F; Ren M; Nie T; Cui J; Chang Z; Li Z
    Clin Infect Dis; 2021 Nov; 73(9):e2552-e2559. PubMed ID: 33320199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.
    Mao Q; Wang Y; Bian L; Xu M; Liang Z
    Emerg Microbes Infect; 2016 Jul; 5(7):e75. PubMed ID: 27436364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hand, Foot, and Mouth Disease Caused by Coxsackievirus A6: A Preliminary Report from Istanbul.
    Ceylan AN; Turel O; Gultepe BS; Inan E; Turkmen AV; Doymaz MZ
    Pol J Microbiol; 2019; 68(2):165-171. PubMed ID: 31257789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.